Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status is updated to indicate no participant enrollment. The record also updates to revision v3.6.0 and removes the previous revision v3.5.5.SummaryDifference0.6%

- Check20 days agoChange DetectedThe history now includes a new revision entry (v3.5.5) reflecting an update to the page's record history, replacing the earlier revision (v3.5.4).SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry v3.5.4 is added to the record history, and the previous v3.5.3 entry is removed. This indicates a small backend update to the page's revision history.SummaryDifference0.1%

- Check56 days agoChange DetectedA new latest revision, v3.5.3, is added to the revision history, replacing the previous v3.5.2; this updates the page's version metadata without altering the study information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history shows Revision: v3.5.2 replacing Revision: v3.5.0.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion 10 adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, IPDSharing, and Document Section to the record, and includes a QC note 'Quality Control Review Has Not Concluded' with a Returned entry dated 2026-03-24.SummaryDifference1%

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.